NEW YORK, Dec. 1, 2023 — Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos”), a clinical-stage […]
Year: 2023
Trulieve Announces Completion of Redemption of All US$130 Million 9.75% Senior Secured Notes due 2024
TALLAHASSEE, Fla., Dec. 1, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the […]
Fathom Holdings Prices Underwritten Public Offering of Common Stock
CARY, N.C., Dec. 1, 2023 — Fathom Holdings Inc. (Nasdaq: FTHM) (“Fathom” or the “Company”), […]
Kazia Therapeutics Announces $2 Million Registered Direct Offering
SYDNEY, Dec. 1, 2023 — Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or the “Company”), an […]
Summit Materials Announces Pricing of $800 Million of 7.250% Senior Notes Due 2031
DENVER, Nov. 30, 2023 — Summit Materials, Inc. (NYSE: SUM, “Summit”) announced today that […]
Golub Capital BDC, Inc. Prices Public Offering of $450 Million 7.050% Notes Due 2028
NEW YORK, Nov. 30, 2023 — Golub Capital BDC, Inc. (the “Company,” “we,” “us” or […]
Fathom Holdings Announces Proposed Primary and Secondary Offering of Common Stock
CARY, N.C., Nov. 30, 2023 — Fathom Holdings Inc. (Nasdaq: FTHM) (“Fathom” or the […]
M3-Brigade Acquisition II Corp. Announces Redemption of Class A Common Stock
NEW YORK, Nov. 30, 2023 — M3-Brigade Acquisition II Corp., a Delaware corporation (the […]
Carrier Global Corporation Announces Closing of €2.35 Billion and $3.0 Billion Notes Offerings
PALM BEACH GARDENS, Fla., Nov. 30, 2023 — Carrier Global Corporation (NYSE: CARR) (“Carrier” […]